June 2020 DAIT Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year (FY) 2022 Concepts

NIAID Division of Allergy, Immunology, and Transplantation Regulatory Management Center (RMC)

For the published request for proposals, see the September 4, 2020 solicitation, NIAID/DAIT Regulatory Management Center (RMC).

NIAID Division of Allergy, Immunology, and Transplantation Clinical Site Monitoring Center (CSMC)

For the published request for proposals, see the February 23, 2021 solicitation, NIAID Clinical Site Monitoring Center (CSMC).

Immune Development in Early Life (IDEaL)

For the published requests for applications, see the January 12, 2021 Guide announcements:

Cohort Studies To Improve Our Understanding of Influenza Immunity, Vaccine Response and Effectiveness in Older Adults (65 years and older)

For the published request for applications, see the September 20, 2020 Guide announcement, Cohort Studies To Improve Our Understanding of Influenza Immunity, Vaccine Response and Effectiveness in Older Adults (65 years and older) (U01 Clinical Trial Not Allowed)

Adjuvant Comparison and Characterization

For the published broad agency announcement, see the March 30, 2021 solicitation, Adjuvant Comparison and Characterization.

Content last reviewed on